Kestra Medical Technologies, Ltd.
KMTS
$24.24
-$0.75-3.00%
NASDAQ
01/31/2025 | 10/31/2024 | 07/31/2024 | 01/31/2024 | ||
---|---|---|---|---|---|
Revenue | 15.09M | 13.75M | 13.75M | 8.28M | |
Total Other Revenue | -- | -- | -- | -- | |
Total Revenue | 15.09M | 13.75M | 13.75M | 8.28M | |
Cost of Revenue | 8.54M | 8.73M | 8.73M | 7.40M | |
Gross Profit | 6.55M | 5.02M | 5.02M | 880.00K | |
SG&A Expenses | 23.80M | 20.34M | 20.34M | 17.09M | |
Depreciation & Amortization | -- | -- | -- | -- | |
Other Operating Expenses | -- | -- | -- | -- | |
Total Operating Expenses | 35.69M | 32.53M | 32.53M | 28.22M | |
Operating Income | -20.60M | -18.78M | -18.78M | -19.95M | |
Income Before Tax | -21.74M | -20.46M | -20.46M | -21.61M | |
Income Tax Expenses | 18.00K | 7.50K | 7.50K | 14.00K | |
Earnings from Continuing Operations | -21.76M | -20.47M | -20.47M | -21.62M | |
Earnings from Discontinued Operations | -- | -- | -- | -- | |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | |
Minority Interest in Earnings | 250.00K | 346.00K | 346.00K | -- | |
Net Income | -21.51M | -20.13M | -20.13M | -21.62M | |
EBIT | -20.60M | -18.78M | -18.78M | -19.95M | |
EBITDA | -18.71M | -16.66M | -16.66M | -16.58M | |
EPS Basic | -1.25 | -217.18 | -217.18 | -1.18 | |
Normalized Basic EPS | -0.67 | -117.61 | -117.61 | -0.68 | |
EPS Diluted | -1.25 | -217.18 | -217.18 | -1.18 | |
Normalized Diluted EPS | -0.67 | -117.61 | -117.61 | -0.68 | |
Average Basic Shares Outstanding | 19.89M | 105.80K | 105.80K | 19.89M | |
Average Diluted Shares Outstanding | 19.89M | 105.80K | 105.80K | 19.89M | |
Dividend Per Share | -- | -- | -- | -- | |
Payout Ratio | -- | -- | -- | -- |